Cargando…
Current and novel biomarkers in anti-neutrophil cytoplasm-associated vasculitis
Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is characterized by a variable disease course, with up to 50% of patients having one relapse within 5 years and many progressing to end-stage organ damage despite modern treatment strategies. Moreover, complications arising from t...
Autores principales: | Draibe, Juliana Bordignon, Fulladosa, Xavier, Cruzado, Josep Maria, Torras, Joan, Salama, Alan David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957731/ https://www.ncbi.nlm.nih.gov/pubmed/27478594 http://dx.doi.org/10.1093/ckj/sfw056 |
Ejemplares similares
-
T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach
por: Martinez Valenzuela, Laura, et al.
Publicado: (2019) -
Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis
por: Martinez Valenzuela, Laura, et al.
Publicado: (2018) -
Exploring Frequencies of Circulating Specific Th17 Cells against Myeloperoxidase and Proteinase 3 in ANCA Associated Vasculitis
por: Martinez Valenzuela, Laura, et al.
Publicado: (2019) -
Combining neutrophil and macrophage biomarkers to detect active disease in ANCA vasculitis: a combinatory model of calprotectin and urine CD163
por: Anton-Pampols, Paula, et al.
Publicado: (2022) -
Treatment of multiple myeloma with renal involvement: the nephrologist’s view
por: Favà, Alexandre, et al.
Publicado: (2018)